The Philips-Teva joint venture has supplied four companies with upwards of $1m in funding as part of its incubator program.
Sanara Ventures, the incubator launched by pharmaceutical company Teva and electronics manufacturer Philips, has revealed some of its investments to Israeli business newspaper Globes.
The unit has so far invested between $1m and $1.15m in four companies: sensor-based telemedicine technology startup HomeDoc, specialized inhaler developer MeWay Pharma, MGD, a respiratory technology spinout from Sheba Medical Center, and a fourth undisclosed startup.
Sanara was formed in January 2015 with $25m of funding pledged for its graduates over an eight-year period.
Assaf…
